bluebird bio Inc (NAS:BLUE)
$ 0.405 0.0272 (7.2%) Market Cap: 78.75 Mil Enterprise Value: 376.50 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 31/100

Q4 2022 bluebird bio Inc Earnings Call Transcript

Mar 29, 2023 / 12:00PM GMT
Release Date Price: $3.26 (-24.54%)
Operator

Good morning, ladies and gentlemen, thank you standing by. Welcome to the bluebird's bio Fourth Quarter and Full Year 2022 Earnings Conference Call. (Operator Instructions) Please note that today's conference may be recorded.

I will now hand the conference over to your speaker host, Courtney O'Leary of Investor Relations. Please go ahead.

Courtney O;Leary
bluebird bio, Inc. - IR Officer

' -

Good morning, everyone, and thank you for joining today's call. I'm Courtney O'Leary, Investor Relations of bluebird bio.

Before we begin, let me review our safe harbor statement.

Today's discussion contains statements that are forward-looking under the Private Securities Litigation Reform Act of 1995, including expectations regarding our future financial results and financial position, in addition to statements of the company's plans, expectations or intentions regarding regulatory progress and commercialization plans.

Such statements are based on current expectations and assumptions that are subject to risks and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot